Scarica l'app Stockscreener
1.04
3.70%
-0.04
Dopo l'orario di chiusura:
1.03
-0.01
-0.96%
Precedente Chiudi:
$1.08
Aprire:
$1.05
Volume 24 ore:
185.34K
Relative Volume:
0.31
Capitalizzazione di mercato:
$31.92M
Reddito:
-
Utile/perdita netta:
$-10.21M
Rapporto P/E:
-1.7802
EPS:
-0.5842
Flusso di cassa netto:
-
1 W Prestazione:
-5.45%
1M Prestazione:
-16.80%
6M Prestazione:
+0.97%
1 anno Prestazione:
-15.45%
Intervallo 1D:
$1.0201
$1.10
Intervallo di 1 settimana:
$1.0201
$1.1383
Portata 52W:
$0.80
$2.60
Neurosense Therapeutics Ltd Stock (NRSN) Company Profile
Nome
Neurosense Therapeutics Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Confronta NRSN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NRSN
Neurosense Therapeutics Ltd
|
1.04 | 31.92M | 0 | -10.21M | 0 | -0.5842 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Neurosense Therapeutics Ltd Borsa (NRSN) Ultime notizie
Is NeuroSense Therapeutics Ltd. stock a safe haven assetWeekly Trade Report & Community Shared Stock Ideas - newser.com
Will NeuroSense Therapeutics Ltd. Equity Warrant stock sustain high P E ratios2025 Earnings Impact & Weekly Top Gainers Trade List - newser.com
Will NeuroSense Therapeutics Ltd. Equity Warrant stock attract more institutional investorsJuly 2025 Weekly Recap & Reliable Intraday Trade Plans - newser.com
What momentum indicators show for NeuroSense Therapeutics Ltd. stockWeekly Trade Report & AI Forecasted Entry and Exit Points - newser.com
Tools to monitor NeuroSense Therapeutics Ltd. recovery probabilityPortfolio Value Summary & Verified Swing Trading Watchlist - newser.com
Tick level data insight on NeuroSense Therapeutics Ltd. Equity Warrant volatilityMarket Volume Report & Fast Exit/Entry Strategy Plans - newser.com
Detecting support and resistance levels for NeuroSense Therapeutics Ltd. Equity Warrant2025 Historical Comparison & Growth Focused Investment Plans - newser.com
How to use a screener to detect NeuroSense Therapeutics Ltd. Equity Warrant breakoutsWeekly Risk Summary & Reliable Intraday Trade Alerts - newser.com
Key metrics from NeuroSense Therapeutics Ltd. Equity Warrant’s quarterly dataMarket Sentiment Review & Risk Adjusted Buy/Sell Alerts - newser.com
Real time scanner hits for NeuroSense Therapeutics Ltd. Equity Warrant explained2025 Volatility Report & Risk Managed Investment Signals - newser.com
Using data tools to time your NeuroSense Therapeutics Ltd. Equity Warrant exit2025 Earnings Surprises & Trade Opportunity Analysis Reports - newser.com
Will NeuroSense Therapeutics Ltd. (H1Z) stock outperform value peers2025 Market Overview & Trade Opportunity Analysis - newser.com
Multi factor analysis applied to NeuroSense Therapeutics Ltd. Equity WarrantPortfolio Growth Summary & Long-Term Investment Growth Plans - newser.com
Can NeuroSense Therapeutics Ltd. Equity Warrant stock deliver strong Q4 earningsEarnings Overview Report & AI Forecasted Entry and Exit Points - newser.com
NeuroSense to Host Investor Webinar on December 8, 2025 - The Malaysian Reserve
2025-11-03 | NeuroSense to Host Investor Webinar on December 8, 2025 | NDAQ:NRSN | Press Release - Stockhouse
Analyzing NeuroSense Therapeutics Ltd. Equity Warrant with multi timeframe chartsIPO Watch & Reliable Breakout Forecasts - newser.com
How moving averages guide NeuroSense Therapeutics Ltd. Equity Warrant tradingTrade Risk Assessment & Low Volatility Stock Suggestions - newser.com
Can volume confirm reversal in NeuroSense Therapeutics Ltd.Earnings Risk Report & AI Driven Stock Reports - newser.com
Using Ichimoku Cloud for NeuroSense Therapeutics Ltd. Equity Warrant technicalsProfit Target & Consistent Return Investment Signals - newser.com
Historical volatility pattern of NeuroSense Therapeutics Ltd. Equity Warrant visualizedQuarterly Earnings Report & Risk Managed Investment Strategies - newser.com
How institutional ownership impacts NeuroSense Therapeutics Ltd. stockJuly 2025 Short Interest & Capital Efficiency Focused Strategies - newser.com
What downside risks could hit NeuroSense Therapeutics Ltd. (H1Z) stockMarket Growth Review & Free Fast Gain Swing Trade Alerts - newser.com
Signal strength of NeuroSense Therapeutics Ltd. stock in tech scannersVolume Spike & Weekly Watchlist of Top Performers - newser.com
Key metrics from NeuroSense Therapeutics Ltd.’s quarterly data2025 Retail Activity & Long-Term Safe Investment Plans - newser.com
Can NeuroSense Therapeutics Ltd. hit a new high this month2025 Short Interest & Long-Term Growth Portfolio Plans - newser.com
Using R and stats models for NeuroSense Therapeutics Ltd. Equity Warrant forecastingQuarterly Market Summary & Technical Pattern Recognition Alerts - newser.com
Visual analytics tools that track NeuroSense Therapeutics Ltd. performanceQuarterly Growth Report & Verified Swing Trading Watchlist - newser.com
Tools to monitor NeuroSense Therapeutics Ltd. Equity Warrant recovery probability2025 Pullback Review & AI Driven Stock Reports - newser.com
How NeuroSense Therapeutics Ltd. Equity Warrant stock performs in stagflation2025 Retail Activity & Real-Time Price Movement Reports - newser.com
Using RSI to spot recovery in NeuroSense Therapeutics Ltd.Weekly Market Summary & Expert-Curated Trade Recommendations - newser.com
Visualizing NeuroSense Therapeutics Ltd. stock with heatmapsJuly 2025 Reactions & Free Safe Capital Growth Stock Tips - newser.com
Is NeuroSense Therapeutics Ltd. showing signs of accumulation2025 Analyst Calls & Safe Entry Point Alerts - newser.com
Neurosense Therapeutics Ltd Azioni (NRSN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.45%
0.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):